Literature DB >> 21431466

Is symptomatic treatment an option for a boy with clinically significant psychotic-like experiences and depressed mood? Comment on Ruhrmann et al., "intervention in at-risk states for developing psychosis." (Eur Arch Psychiatry Clin Neurosci 260 Suppl 2:S90-94).

Hsiang-Yuan Lin, Yen-Nan Chiu, Chen-Chung Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21431466     DOI： 10.1007/s00406-011-0210-x

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  10 in total

Review 1.  Ethics and early intervention in psychosis: keeping up the pace and staying in step.

Authors:  P D McGorry; A Yung; L Phillips
Journal:  Schizophr Res       Date:  2001-08-01       Impact factor: 4.939

Review 2.  Intervention in at-risk states for developing psychosis.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Andreas Bechdolf; Joachim Klosterkötter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-14       Impact factor: 5.270

3.  Can antidepressants prevent psychosis?

Authors:  Paolo Fusar-Poli; Lucia Valmaggia; Philip McGuire
Journal:  Lancet       Date:  2007-11-24       Impact factor: 79.321

4.  The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV.

Authors:  Stephanie E Meyer; Carrie E Bearden; Sabrina R Lux; Jamie L Gordon; Jennifer K Johnson; Mary P O'Brien; Tara A Niendam; Rachel L Loewy; Joseph Ventura; Tyrone D Cannon
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-06       Impact factor: 2.576

Review 5.  The prodromal phase of first-episode psychosis: past and current conceptualizations.

Authors:  A R Yung; P D McGorry
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

6.  Probably at-risk, but certainly ill--advocating the introduction of a psychosis spectrum disorder in DSM-V.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Joachim Klosterkötter
Journal:  Schizophr Res       Date:  2010-04-18       Impact factor: 4.939

7.  Antidepressants in child and adolescent depression: where are the bugs?

Authors:  C Moreno; C Arango; M Parellada; D Shaffer; H Bird
Journal:  Acta Psychiatr Scand       Date:  2007-03       Impact factor: 6.392

8.  A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.

Authors:  Robert L Findling; Adelaide Robb; Margaretta Nyilas; Robert A Forbes; Na Jin; Svetlana Ivanova; Ronald Marcus; Robert D McQuade; Taro Iwamoto; William H Carson
Journal:  Am J Psychiatry       Date:  2008-09-02       Impact factor: 18.112

9.  Effects of aripiprazole on insight and subjective experience in individuals with an at-risk mental state.

Authors:  Hiroyuki Kobayashi; Keiko Morita; Kiyoaki Takeshi; Hiroki Koshikawa; Ryoko Yamazawa; Haruo Kashima; Masafumi Mizuno
Journal:  J Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.153

10.  Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study.

Authors:  Scott W Woods; Elizabeth M Tully; Barbara C Walsh; Keith A Hawkins; Jennifer L Callahan; Shuki J Cohen; Daniel H Mathalon; Tandy J Miller; Thomas H McGlashan
Journal:  Br J Psychiatry Suppl       Date:  2007-12
  10 in total
  1 in total

Review 1.  Antipsychotic interventions in prodromal psychosis: safety issues.

Authors:  Chen-Chung Liu; Arsime Demjaha
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.